Skip to main content

Germany Moves A Step Closer Towards Legalization

It was a big day in Germany for cannabis policy, with Germany’s Health Minister Karl Lauterbach making a formal cannabis legalization presentation to the federal cabinet. While the presentation did not involve the formal introduction of legislation, it did serve as the closest thing to a comprehensive status update so far in the German legalization process.

Much of what was presented today was already known via an interesting week of policy leaks and public statements by elected officials. Although, there were some items of note from the presentation, including news that prior to a formal measure being introduced Germany will continue to seek approval from the European Union.

“Berlin will check with the European Union’s executive commission whether the plan approved by the German government is in line with EU laws and would proceed with legislation “on this basis” only if it gets the green light, Health Minister Karl Lauterbach said” according to ABC News.

Per Health Minister Lauterbach, Germany will continue to examine whether regulated social consumption will be allowed, as well as the sale of edibles, however, the current plan does not permit for either of those policy and industry components.

Pending successful movement on the European Union approval front, Health Minister Lauterbach indicated that a formal bill would be introduced for lawmakers’ consideration in 2023, with legalization hopefully becoming law by 2024. Below is Health Minister Lauterbach’s presentation in full (broadcast in German):

German Legalization Plan Continues To Evolve After Public Outcry

Last week I wrote about the reported leaking of components of a long awaited German legalization plan. The legalization details were reportedly from Health Minister Karl Lauterbach (SPD), and provided the first deep dive opportunity for global cannabis policy and industry observers who have all been heavily focused on all things cannabis and Germany ever since the dust settled on the 2021 federal election. German voters elected a new governing coalition in 2021 and the coalition, often referred to as the Traffic Light Coalition, quickly indicated its intent to pass a legalization measure and launch a regulated adult-use industry.

A new report is out today from The Rheinischer Post which indicates that Health Minister Karl Lauterbach will present a legalization plan to the federal cabinet tomorrow. The new report also indicates that some components of the plan have evolved after significant public pushback occurred regarding the previously leaked components.

As I touched on in my previous article, it’s a common political strategy to ‘float political balloons’ via leaks and public comments to see if the public ‘pops’ the metaphorical balloons in the form of public outcry. Lawmakers use that strategy during political negotiations from time to time to force their opponents to relent to some degree. I suspect that is what happened last week given the fact that the measure seems to have improved post-outcry, although admittedly, that is just conjecture on my part. Regardless, the evolved components of the plan are significant nonetheless, and are the exact ones that were the main focus of public pushback.

What Changed And What Remained The Same?

The legal age for adult-use cannabis, 18 years old, was unchanged in the reported latest version of Germany’s legalization plan, which was expected. The initial 20 gram possession limit appears to now be described as ‘a maximum of 20 to 30 grams.’ Public outcry regarding possession limits was not limited to just citizens, as deputy FDP chairman Johannes Vogel was also very vocal about his opposition to the 20 gram limit. A prohibition on advertising remained unchanged, as well as the types of outlets that may be allowed to legally sell adult-use cannabis (licensed stores and pharmacies).

Arguably the greatest differences between the components leaked last week compared to what is going to be reportedly presented tomorrow hinges on THC limits for products. Initially, it was being reported that there would be a 15% THC limit on products sold to people over 21, and a separate 10% THC limit on products sold to people of legal age under 21. Per The Rheinischer Post’s reporting (translated to English), there will be no cap for people 21 and over, however, “Because of the increased risk of cannabis-related brain damage in adolescence, it is being examined whether an upper limit for the intoxicating substance THC will be set for adults up to the age of 21, according to the paper.”

Another significant change from last week’s version of the plan compared to this week’s pertains to home cultivation. Last week’s version reportedly involved a two plant limit for home cultivation, however, this week’s version has a three plant home cultivation limit. By comparison, in Malta adult households can cultivate up to four cannabis plants. Malta is the only country in Europe that has passed an adult-use cannabis legalization measure, although adult-use cannabis sales remain prohibited in Malta.

Will There Be More Changes?

If there is one major takeaway from what has transpired in Germany over the course of the last week, it’s that the legalization process is still very much ongoing. It is virtually guaranteed that there will be further tweaks made to the legalization plan in Germany, and it’s largely just a question of what will change. Furthermore, even the evolved plan still leaves quite a few extremely important items to finalize, including the actual personal possession limit, potential THC limits for products sold to younger adults, and laws pertaining to edibles. And all the while there are still continental and international treaty concerns to be worked out.

As The Rheinischer Post stated in it’s coverage (translated to English), “The cabinet referral is an intermediate step.” The political process can be full of twists and turns, especially when it involves something as monumental as launching the world’s largest legal cannabis market. Currently, the only public policy and regulation ‘guidebook’ for launching a national adult-use cannabis industry open to the world is Canada, and for a multitude of reasons Germany is an entirely different situation compared to Canada. Germany can learn some things from Canada to be sure, however, much of the heavy political and regulatory lifting in Germany is completely unique, and as such, people would be wise to anticipate more changes in the future, albeit more on the fringes versus a complete overhaul. For cannabis advocates specifically, it’s wise to remain vocal and keep the pressure on because, as we witnessed over the course of the last week, that pressure can result in improved changes to what is being proposed in Germany.

Brazil’s Federal Council Of Medicine Creates Confusion With New Cannabis Guidance

Brazil is the most populous country in South America. With a population of over 200 million people, Brazil makes up almost half the population on the continent and dwarfs the next most populous country in South America, Colombia (roughly 50 million people).

It’s a safe bet that there are a considerable number of suffering patients in Brazil, many of which that would likely benefit from using one or more types of cannabis products for medical purposes.

Unfortunately, Brazil’s medical cannabis program is still limited in many ways, with many suffering patients not qualifying for the country’s emerging medical cannabis program because their condition or conditions are not on the list of those that qualify for safe access.

To make matters worse, the nation’s Federal Council of Medicine issued new guidance this month that would further limit who can qualify to receive medical cannabis. Per Globo:

Eight years after its last guidance on the use of cannabidiol, the Federal Council of Medicine (CFM) published this Friday (14) a new standard aimed at guiding how doctors should treat the subject.

With no advances and more restrictive, CFM resolution No. 2,324 authorizes cannabis products to be used only to treat some cases of epilepsy. The text also prohibits the prescription of “any other derivatives (of cannabis sativa) other than cannabidiol”.

The new guidance is the target of considerable pushback from a wide array of stakeholders, and not just patients. Members of the emerging cannabis industry, as well as members of the medical community, were quick to offer criticism.

One major point that is being made by experts from all types of backgrounds is that Brazil had previously authorized the sale of CBD medication for multiple sclerosis in pharmacies. The new guidance obviously contradicts that prior authorization, as well as other practices that are common in Brazil right now.

The guidance puts doctors in a really tough situation and clearly limits their ability to treat patients. It will be interesting to see if the guidance is actually incorporated, or if it is legally challenged and/or scraped in the future.

Are Legal Cannabis Sales Coming To Czechia In 2024?

Ever since Germany’s governing coalition announced its intent to pass an adult-use legalization measure and launch a regulated industry, the tone of the cannabis discussion in many European countries instantly changed.

One of those countries is the Czech Republic, also known as Czechia, which shares a 815 kilometer border with Germany. Cannabis reform discussions were already well underway in Czechia, however, they have heated up recently with national anti-drug coordinator Jindřich Vobořil discussing a legalization and regulation proposal with members of the press earlier this week. Per Radio Prague International:

If national anti-drug coordinator Jindřich Vobořil’s proposed plan comes into effect in 2024 as he hopes, Czechia could become the second EU country to legalise the recreational use of cannabis. And not only that – it would even go a step further, also making its sale legal. The anti-drug coordinator presented his plan for combatting addiction – which includes the proposal to legalise cannabis – at a press conference this week.

“At the moment, there is a political consensus for me to create this proposal for the regulation of cannabis, a substance which is illegal at the moment. We want to regulate it with the help of the market and we believe that this regulation will be more effective than the current ban.”

Of course, a lot can happen between now and 2024, and that goes for outside of Czechia’s borders as much as inside of its borders. Perhaps even more so outside of its borders. After all, lawmakers in Czechia are not holding their cannabis discussions in a vacuum.

Cannabis reform is obviously on the move in Germany, and it’s quite possible that legal adult-use sales could launch there by the end of 2024. Other countries in Europe are also trending towards legalization, although perhaps not as quickly and robustly.

Any foot dragging in Czechia comes with an opportunity cost. If lawmakers want to cling to prohibition, and wait until after other countries have already launched industries, once-in-a-lifetime opportunities for its citizens will be gone forever.

New Data Creates Cannabis Controversy In New Zealand

A little over a week ago we published an article describing how New Zealand’s Justice Minister threw cold water on calls for the nation to reform its cannabis laws. Calls had ramped up after United States President Joe Biden announced a plan to issue pardons to people convicted of federal cannabis possession in the U.S.

New Zealand Justice Minister Kiri Allan offered up various reasons for why new cannabis reform measures would not be pursued, specifically referencing a measure from 2019 that provided flexibility to law enforcement for cannabis cases.

“We have a slightly different context here. In 2019, we introduced the ability for the police to exercise discretion when it came to possession of cannabis offences,” Minister Allan stated earlier this month according to RNZ. “Subsequently, we’ve seen a radical reduction in terms of those that are convicted merely for cannabis possession.”

New data obtained by Newshub is putting into proper context how misleading Minister Allan’s claim truly is. Below is a chart of the actual cannabis enforcement numbers, via Newshub:

Cannabis-Possession-Court-Action-Newshub-1120

To be fair, the number of court actions did technically reduce from August 2019 to July 2022, however, it is clearly not enough of a reduction to be properly described as a “radical reduction” and certainly not enough of a reduction to warrant keeping cannabis prohibition in place.

Whenever members of law enforcement are allowed to decide when to arrest someone and when not to, it creates a situation that is ripe for selective enforcement. The only way to ensure that doesn’t happen is to end cannabis prohibition.

Cannabis advocates inside and outside of New Zealand will continue to call for meaningful reform regardless of the misleading talking points that are offered up by opponents. As momentum continues to increase outside of New Zealand’s borders for legalization it will become increasingly difficult for prohibitionists to maintain the status quo.

Support For Cannabis Pardons Increases In Canada

Canada was the first G-7 nation to pass a nationwide adult-use cannabis legalization measure, which occurred just over four years ago. To-date Canada still serves as the only national adult-use cannabis market where anyone of legal age can purchase products beyond the low-THC variety.

Only two other nations have passed national legalization measures, with Uruguay having done so years before Canada, and Malta having done so late last year. Unlike Canada, Uruguay limits legal adult-use cannabis purchases to residents only, and Malta does not currently allow for-profit sales to anyone.

One area where Canada’s legalization model is clearly lacking is when it comes to pardons. United States President Joe Biden recently announced that he will be pardoning anyone convicted of a federal cannabis possession charge, and that has ramped up calls in Canada for the government at all levels to do the same.

Leading up to legalization in 2018 in Canada there was strong support for automatic pardons, yet the provision did not make it into the final measure. Instead, the fee for applying for a cannabis pardon was eliminated as a political compromise, although that still left all of the hoops that needed to be jumped through.

“According to a poll by The Globe and Mail/Nanos Research, however, 62 per cent of Canadians support or somewhat support the calls for a pardon for every person with a criminal record for marijuana possession.” The Globe and Mail stated back in 2017.

That level of support appears to have increased between 2017 and 2022, with new polling showing a slight uptick. Per Research Co:

More than three-in-five Canadians are in favour of a plan to pardon people convicted of simple possession of marijuana, a new Research Co. poll has found.

In the online survey of a representative national sample, 64% of Canadians agree with the federal government providing expungement orders to people convicted of possession of cannabis for personal use with no intent to traffic.

It still appears to be unclear how many people in Canada have one or more related cannabis convictions on their record that would be eligible for expungement. Starting in the 1970s tens of thousands of people were convicted of possession every year in Canada. In 2015 alone it’s estimated that roughly 49,000 charges were applied by law enforcement.

Cannabis pardons and expungements need to be automatic, and that needs to be the practice everywhere, including in Canada.

The harms of prohibition are numerous, and the wrongs of the past will never be righted until every person that was ever convicted of a cannabis offense is freed from the burden of having it follow them around everywhere that they go. And the burden of making that happen falls squarely on the government, not the victim.

Leaked German Legalization Points From Health Minister – Homegrow, Retail Stores, And Possession Of Up To 20 Grams

This morning it is being reported that long-awaited key points of a German adult-use legalization plan were made available to Germany’s media community. The provisions being leaked out there are reportedly from Health Minister Karl Lauterbach (SPD), and are providing tremendous insight into what a finalized coalition plan may look like. Obviously, there’s still a lot of political lifting to be performed between now and when someone is physically purchasing regulated adult-use cannabis in Germany, however, this is the first look of its type into what the governing coalition is at the very least strongly considering, if not outright trying to implement.

Last year Germany elected a new coalition government, and after the dust settled on the election results the coalition made it abundantly clear that it was going to pursue adult-use legalization and the launch of a regulated national industry. To date, only Uruguay, Canada, and Malta have passed a national adult-use measure, and out of the three, only Canada has a regulated adult-use sales system that is open to anyone of legal age regardless of citizenship status.

What Provisions Are Involved?

According to the initial reporting from RND, the legalization components that are involved originated from the Health Ministry, and the plan “is currently being coordinated among the [other] ministries involved,” which is leading many to believe that there still could be some changes made to what is being floated out there. As I previously touched on, there’s still a lot of time left on the clock to use a sports metaphor.

In my opinion, the provisions were leaked versus announced in order to see what the reactions were from the public and international community, with the possible plan to make tweaks accordingly. That’s just conjecture on my part, but it is a common political communications tactic, particularly with legislation of this magnitude. It’s a great way to gain feedback and insight while also mitigating controversy. With that being said, below are some of the major components involved in today’s news:

  • 18 years old is the legal age to purchase/possess cannabis
  • A 20 gram possession limit
  • Home cultivation of up to 2 plants
  • A 15% THC cap limit on products sold to people over 21
  • A 10% THC cap limit on products sold to people 18-21
  • Retail buffer zones around schools and other specified establishments
  • A general ban on industry advertising
  • Outlets would include, but not be limited to, pharmacies
  • Possibly allowing shops to have ‘consumption options’
  • A possible tax assessment based on THC content
  • All cannabis for the market will be cultivated domestically

“The Federal Ministry of Health did not confirm the RND report on request and referred to ongoing votes in the federal government. A Lauterbach spokesman said the departments of health, justice, economy, nutrition and the Federal Foreign Office were working together to implement the coalition agreement. Lauterbach had announced a key issues paper for the fall and a draft law for the end of the year.” RND stated in its reporting.

Room For Improvement And Clarification

Here in the United States, where I live, the state-level legal age for cannabis is 21. The legal age in Canada and Uruguay is also 18. Malta, which was the first nation to legalize cannabis for adult use in Europe, also has a legal age of 18, although sales are currently not permitted in Malta. I have always felt that if someone is old enough to vote for legalization, or for candidates that support it, then they are old enough to participate in a legal market. Regardless, allowing industry access to people 18-21 obviously expands the market base, albeit with the apparent potential for a different THC product limit for that subset of customers.

The 20 gram possession limit is considerably greater than what is allowed in Malta away from a person’s home. In Malta, the possession limit away from a person’s home is only 7 grams, although up to 50 grams is allowed within a person’s home, along with up to four plants. The two plant cultivation limit that is being reported out of Germany is drawing some pushback, as many feel that the limit is too low. One thing that could prove to be problematic is the possession limit combined with the plant limit, as even one healthy cannabis plant cultivated in a closet can yield far greater than 20 grams of cannabis. It seems that more could be done to harmonize the two limits in order to help mitigate any issues for consumers come harvest time.

The retail buffer zones and advertising bans were to be expected, and I certainly think that they will ultimately make it into whatever final version of a legalization model is adopted. Advertising bans can be tricky to enforce given how many different ways people get their information these days, particularly on the internet, however, we will have to wait and see what enforcement strategies may entail. The reported THC caps may be the most confusing aspect of what was reported today, in that it seems to be unclear if that will apply to things like vape pen cartridges and cannabis concentrates. It’s common for products in other legal markets of those types to contain a considerably larger THC percentage than 10-15%. That’s something that will need to be further addressed in a finalized plan.

The German Retail Model Is Taking Shape

Arguably the most insightful components of today’s news related to how cannabis will be sourced, sold, and consumed in Germany once a legal, regulated market is launched. Ever since a push to legalize was announced, many cannabis observers around the world wondered if adult-use cannabis sales would be limited to pharmacies? If what is being reported today eventually becomes adopted, then the retail options for consumers will be far more robust. In addition to pharmacies, cannabis would also be sold in dedicated stores, and possibly via the internet, which is currently an option in Canada.

Other components that were leaked today could change and evolve, however, the basic sales outlet model provisions are likely to remain the same from a macro perspective. Again, there’s still a lot of lifting to be done to get something across the finish line, yet I think it’s safe to assume that once legal sales are launched in Germany they will be allowed via a number of different ways beyond just at pharmacies. Legal social consumption lounges seem to be a very real possibility too based on what we have seen today.

The domestic cultivation part also seems to be a component that will be set in stone, at least for the foreseeable future, and the significance of that cannot be overstated. In order to get around issues with international and continental treaties, it sounds like all cannabis for the adult-use market will need to be produced within Germany’s borders. I assume that will be completely separate from medical products, which will presumably still be imported in addition to being produced domestically.

As I have pointed out countless times in my articles, the German market will not just involve consumers from Germany. Germany shares more borders with other countries than any other nation in Europe – nine total. When Germany inevitably launches legal adult-use sales, it will be largely doing so for the entire European continent, as well as for any tourists that will no doubt flock to Germany in record numbers from other continents to partake in the newly established freedoms. I don’t know exactly how much German cannabis supply will be needed to match the demand that will be flooding into Germany’s borders, but it’s a very safe bet that it’s going to be unlike anything that the legal market has ever seen before, and cultivation licenses within Germany’s borders are going to likely become the most sought after cannabis licenses on earth as a result.c

Who Legalizes First – The United States Or Germany?

When it comes to cannabis policy there are two nations that likely have more eyes watching them right now than any other countries on the planet – Germany and the United States. It is no secret that many lawmakers in Germany are working really hard right now to determine which provisions should be included in a national cannabis legalization and industry model. It is also no secret that United States President Joe Biden recently tasked federal Departments with re-examining cannabis’ current status in the U.S.

Efforts to reform national cannabis policies in both countries are making headlines, and understandably so, as both Germany and the United States are home to two of the largest economies on earth, and both countries wield tremendous political influence around the world. However, that is not to say that the efforts in both nations are on the same trajectory or timeline, as that will almost certainly prove to not be the case. One nation is far more likely to legalize at the national level soon than the other one.

Germany Is ‘In The Lead’

One thing that is always important to point out is that nothing is guaranteed in the world of politics. With so much rhetoric being thrown around by lawmakers and aspiring lawmakers, especially these days, nearly everything needs to be taken with a grain of salt. As the old saying goes, ‘actions speak louder than words,’ and from that perspective Germany is clearly farther along in its effort to legalize nationally compared to the United States.

The current governing coalition in Germany previously announced direct intent to legalize cannabis for adult-use and to launch a regulated national industry. Since that time, many members of the governing coalition have engaged with stakeholders in multiple ways, gaining insight and feedback, and working meaningfully towards their goal. The process is not going as fast as many had hoped, however, just as Rome wasn’t built in a day the same is obviously true for a country trying to launch what will instantly become the world’s largest regulated cannabis market by far.

Compare that to the United States where things are much more fractured, both from a governing standpoint and an industry standpoint. Yes, President Biden did issue pardons for simple possession and tasked Department leaders with re-examining cannabis’ current federal status. However, that is not the same as Biden taking the lead on pushing for a regulated national industry. It’s quite possible that nothing could occur between now and when Biden is up for re-election, and it’s anyone’s guess where things go from there if/when he is not re-elected.

Furthermore, Biden can only do so much, as the burden for much of the work that needs to be performed lies on the shoulders of Congress. The current Congress has failed to get even a limited legalization measure passed, and with another election looming next month, the deck will be re-shuffled and likely in a manner that doesn’t move the needle. In fact, if the needle is moved, it will likely be in the wrong direction given historical midterm election trends in the U.S.

Adding To Momentum

Make no mistake – both the United States and Germany will legalize federally sooner rather than later, although, Germany is likely to do so on a quicker timeline compared to the U.S. Whereas Germany will presumably legalize nationally in one fell swoop, the U.S. will continue to see state after state pass their own legalization measures until the point where it reaches such a critical mass that it tips the scales. And just as every state that legalizes adds to the momentum for federal reform in the U.S., so too will legalization in Germany add to the momentum of efforts in the U.S.

The United States would be a larger domino between the two countries given that the United States has historically led the charge on prohibition and its economy is bigger. Yet, that doesn’t seem to be on the horizon in the U.S. The two largest economies behind the United States are China and Japan, and neither of those countries will be legalizing anytime soon, unfortunately. That puts the spotlight squarely on Germany, and once the German prohibition domino falls it’s going to speed things up everywhere else on earth, including in the United States.

Health Canada Is Seeking Feedback After Four Years Of Legalization

Canada was not the first country to legalize cannabis for adult-use, however, it was the first G-7 nation to do so, and the first to implement a nationwide, regulated adult-use cannabis industry that is open to anyone of legal age.

Uruguay is the only nation to have passed an adult-use legalization measure prior to Canada doing so. Yet, unlike Canada’s industry model, Uruguay limits adult-use sales to residents.

Legalization in Canada has certainly experienced its ups and downs, and by no means is it perfect. With that being said, it’s still the greatest cannabis policy and industry ‘experiment’ to-date, and much can be learned from the last four years.

On that note, Health Canada issued a statement today recapping its views regarding the last four years. Part of the statement urges people to share their feedback. Below is the statement in its entirety:

OTTAWA, ONOct. 17, 2022 /CNW Telbec/ – Today, the Minister of Health and the Minister of Mental Health and Addictions and Associate Minister of Health issued the following statement about the Cannabis Act:

On this day in 2018, the Cannabis Act came into force, putting in place a new, strictly regulated framework for controlling the sale, possession, production and distribution of legalized and regulated cannabis for non-medical purposes.

Since this time, the Government of Canada has implemented a robust public health approach to help keep cannabis out of the hands of youth and to help ensure adults have access to a quality-controlled and regulated supply, while reducing the scope and scale of the illicit market.

The Cannabis Act has two important and critical objectives: first, it protects the health and safety of Canadians while serving as a flexible legislative framework that adapts and responds to the ongoing and emerging needs of Canadians; second, it provides for the establishment of a diverse and competitive legal industry made up of small and large players to displace the illicit market.

In the short time since legalization, more and more Canadians who consume cannabis are choosing to buy cannabis from legal retailers - according to the 2021 Canadian Cannabis Survey, 53% reported a legal storefront as their usual source, an increase from 41% in 2020.

Public education efforts play an important role in protecting the health and safety of Canadians, especially youth. We will continue to equip Canadians with trusted information about how to identify legal cannabis and lower their risk if they choose to consume.

To ensure the functioning of the Cannabis Act is continuously improving, Health Canada has launched an independent review of the legislation to examine the progress made towards achieving the Act’s objectives, and to help identify priority areas for improvement. An Expert Panel, chaired by Mr. Morris Rosenberg, will lead this credible and inclusive review.

As an initial step, an online engagement process has been launched and is open to all Canadians. We encourage you to read Taking Stock of Progress: Cannabis Legalization and Regulation in Canada and to share your views via the online questionnaire or through written feedback until November 21, 2022.

First Nations, Inuit, and Métis peoples are also invited to read and provide feedback by November 21, 2022, on the Summary from Engagement with First Nations, Inuit and Métis Peoples.

As we look to the future, the Government of Canada will continue to provide clear, consistent and evidence-based information on the health and safety effects of cannabis use to people across the country, so they can better understand the risks and make more informed choices.

The Honourable Jean-Yves Duclos, P.C., M.P.
The Honourable Carolyn Bennett, P.C., M.P.

Associated links
Reduce your risk: Choose legal cannabis 
Cannabis Resource Series – How to read and understand a cannabis product label 
Pursue your Passion campaign 
Authorized cannabis retailers in the provinces and territories 
Canada’s lower-risk cannabis use guidelines
Accidental ingestion of illegal “copycat” edible cannabis products causing serious harm to children: Public Advisory 
Canadian Cannabis Survey 2021: Summary

SOURCE Health Canada

For further information: Marie-France Proulx, Press Secretary, Office of the Honourable Jean-Yves Duclos, Minister of Health, 613-957-0200; Maja Staka, Office of the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, 343-552-5568; Media Relations, Health Canada, 613-957-2983, media@hc-sc.gc.ca